Legend Biotech (LEGN) Other Non-Current Assets (2020 - 2025)

Legend Biotech (LEGN) has 6 years of Other Non-Current Assets data on file, last reported at $12.4 million in Q4 2025.

• In Q4 2025, Other Non-Current Assets fell 4.62% year-over-year to $12.4 million; the TTM figure through Dec 2025 stood at $12.4 million (down 4.62% YoY), while the FY2025 annual figure was $12.4 million, down 4.62% from the prior year.
• Other Non-Current Assets grew to $12.4 million in Q4 2025, from $11.0 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $24.6 million in Q1 2022 and bottomed at $3983.0 in Q1 2021.
• A 5-year average of $5.5 million and a median of $3.3 million in 2021 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 618102.36% — and 2023, when it sank 95.69%.
• Year by year, Other Non-Current Assets stood at $5.1 million in 2021, then tumbled by 71.11% to $1.5 million in 2022, then gained by 0.4% to $1.5 million in 2023, then jumped by 770.73% to $13.0 million in 2024, then decreased by 4.62% to $12.4 million in 2025.
• The last three Other Non-Current Assets figures came in at $12.4 million (Q4 2025), $11.0 million (Q3 2025), and $5.7 million (Q2 2025), per Business Quant data.

Peer Comparison